Please provide your email address to receive an email when new articles are posted on . BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Paulo-Eduardo Stanga, MD, ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. SEATTLE — In this Healio Video Perspective from the ARVO ...
As a child, Max Hodak learned to develop film in a darkroom with his grandfather who was almost blind. Hodak's grandfather had retinitis pigmentosa, a congenital disease that affects one out of every ...
DALLAS, Dec. 2, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor ...
BOSTON, Nov. 12, 2025 /PRNewswire/ -- Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced today the closing of its Seed funding ...
CNN — A blind man has had his vision partially restored using optogenetic therapy and engineered goggles -- the first successful case of such therapy in humans. Researchers treated a 58-year-old man ...
- Company will advance RTx-021 for the treatment of geographic atrophy age-related macular degeneration SAN FRANCISCO--(BUSINESS WIRE)--Ray Therapeutics, a leading optogenetics company, announced ...
One of the hallmarks of cancer cells is their ability to evade apoptosis, or programmed cell death, through changes in protein expression. Inducing apoptosis in cancer cells has become a major focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results